PDL BioPharma Inc. (PDLI)

2.29
0.04 2.00
NASDAQ : Health Technology
Prev Close 2.24
Open 2.23
Day Low/High 2.21 / 2.29
52 Wk Low/High 2.21 / 3.89
Volume 901.53K
Avg Volume 1.15M
Exchange NASDAQ
Shares Outstanding 114.20M
Market Cap 270.66M
EPS -0.50
P/E Ratio 7.93
Div & Yield N.A. (N.A)
3 Buy-Rated Dividend Stocks: OKS, PDLI, RGR

3 Buy-Rated Dividend Stocks: OKS, PDLI, RGR

These 3 dividend stocks are rated a Buy by TheStreet Ratings Group

4 Stocks Going Ex-Dividend Monday: PDLI, FLO, LUV, HAL

4 Stocks Going Ex-Dividend Monday: PDLI, FLO, LUV, HAL

PDLI FLO LUV HAL are going ex-dividend Monday, June 3, 2013

5 Buy-Rated Dividend Stocks: EPR, ORI, GAS, PDLI, HE

5 Buy-Rated Dividend Stocks: EPR, ORI, GAS, PDLI, HE

These 5 dividend stocks are rated a Buy by TheStreet Ratings Group

'Mad Money' Lightning Round: Ford Is a Buy

'Mad Money' Lightning Round: Ford Is a Buy

Cramer also likes Berkshire Hathaway but is steering clear of 3D Systems.

Cramer's 'Mad Money' Recap: Google vs. Apple

Cramer's 'Mad Money' Recap: Google vs. Apple

Google is outperforming while no one knows what's going on at Apple, Cramer said.

4 Buy-Rated Dividend Stocks: COP, ETE, PDLI, TEG

4 Buy-Rated Dividend Stocks: COP, ETE, PDLI, TEG

These 4 dividend stocks are rated a Buy by TheStreet Ratings Group

3 Buy-Rated Dividend Stocks

3 Buy-Rated Dividend Stocks

These 3 dividend stocks are rated a Buy by TheStreet Ratings Group

PDL BioPharma (PDLI) Shares Cross Below 200 DMA

PDL BioPharma (PDLI) Shares Cross Below 200 DMA

In trading on Wednesday, shares of PDL BioPharma Inc crossed below their 200 day moving average of $7.32, changing hands as low as $7.31 per share. PDL BioPharma Inc shares are currently trading down about 1.5% on the day.

5 Buy-Rated Dividend Stocks

5 Buy-Rated Dividend Stocks

These 5 dividend stocks are rated a Buy by TheStreet Ratings Group

3 Buy-Rated Dividend Stocks

3 Buy-Rated Dividend Stocks

These 3 dividend stocks are rated a Buy by TheStreet Ratings Group

2 Drug Stocks Under $10 To Pick As Favorites

2 Drug Stocks Under $10 To Pick As Favorites

Chris Lau, Kapitall: If there was a recent mild sell-offs in the stock market, investors would not really notice it. Wide [...]

'Mad Money' Lightning Round: Stay Away From Intel

'Mad Money' Lightning Round: Stay Away From Intel

Cramer has no appetite for McDonald's, Align or MGM but thinks Yamaha and the gold ETF shine.

Cramer's 'Mad Money' Recap: Politics Is Overrated

Cramer's 'Mad Money' Recap: Politics Is Overrated

What really matters to stock prices, Cramer said, is management and a company's business model, not who happens to occupy the White House.

PDL BioPharma Inc. Stock Upgraded (PDLI)

PDL BioPharma Inc. Stock Upgraded (PDLI)

PDL BioPharma (Nasdaq:PDLI) has been upgraded by TheStreet Ratings from a hold to buy.

AxoGen, Inc. Completes $20.8 Million Financing With PDL BioPharma, Inc.

AxoGen, Inc. Completes $20.8 Million Financing With PDL BioPharma, Inc.

AxoGen, Inc. (AxoGen) (OTCBB: AXGN), and PDL BioPharma, Inc.

Cramer's 'Mad Money' Recap: Next Week's Game Plan

Cramer's 'Mad Money' Recap: Next Week's Game Plan

The nonfarm payroll report will be the most important economic data we see next week, Cramer said.

PDL BioPharma's CEO Discusses Q2 2012 Results - Earnings Call Transcript

PDL BioPharma's CEO Discusses Q2 2012 Results - Earnings Call Transcript

PDL BioPharma's CEO Discusses Q2 2012 Results - Earnings Call Transcript

The Cream of Healthcare

Even given the sharp climb in these stocks, they likely still have room to run.

5 Hated Stocks Set to Soar on Earnings

5 Hated Stocks Set to Soar on Earnings

These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.

PDL BioPharma President Presents At Goldman Sachs Annual Global Healthcare Conference (Transcript)

PDL BioPharma President Presents At Goldman Sachs Annual Global Healthcare Conference (Transcript)

PDL BioPharma President Presents at Goldman Sachs Annual Global Healthcare Conference (Transcript)

PDL BioPharma Stock To Go Ex-dividend Tomorrow (PDLI)

PDL BioPharma Stock To Go Ex-dividend Tomorrow (PDLI)

The ex-dividend date for PDL BioPharma (Nasdaq:PDLI) is tomorrow, June 5, 2012. Owners of shares as of market close today will be eligible for a dividend of 15 cents per share. At a price of $6.33 as of 9:30 a.m., the dividend yield is 9.3%.

PDL BioPharma's CEO Discusses Q1 2012 Results - Earnings Call Transcript

PDL BioPharma's CEO Discusses Q1 2012 Results - Earnings Call Transcript

PDL BioPharma's CEO Discusses Q1 2012 Results - Earnings Call Transcript

PDL BioPharma Stock To Go Ex-dividend Monday (PDLI)

PDL BioPharma Stock To Go Ex-dividend Monday (PDLI)

The ex-dividend date for PDL BioPharma (Nasdaq:PDLI) is Monday, March 5, 2012. Owners of shares as of market close today will be eligible for a dividend of 15 cents per share. At a price of $6.52 as of 10 a.m., the dividend yield is 9.4%.

PDL BioPharma's CEO Discusses Q4 2011 Results - Earnings Call Transcript

PDL BioPharma's CEO Discusses Q4 2011 Results - Earnings Call Transcript

PDL BioPharma's CEO Discusses Q4 2011 Results - Earnings Call Transcript

Time to Read the Reports

I found some time to focus on the growing stack of 13HF filings that have been dribbling in.

PDL BioPharma's CEO Presents At 30th Annual JP Morgan Healthcare Conference (Transcript)

PDL BioPharma's CEO Presents At 30th Annual JP Morgan Healthcare Conference (Transcript)

PDL BioPharma's CEO Presents at 30th Annual JP Morgan Healthcare Conference (Transcript)

Stocks to Watch: Vulcan, Zynga, Winn-Dixie (Update 2)

Stocks to Watch: Vulcan, Zynga, Winn-Dixie (Update 2)

Vulcan shares rise after the company files a lawsuit charging that Martin Marietta had been 'covertly' plotting a hostile bid. Martin Marietta says it's not dissuaded by the move.

PDL BioPharma Stock To Go Ex-dividend Tomorrow (PDLI)

PDL BioPharma Stock To Go Ex-dividend Tomorrow (PDLI)

The ex-dividend date for PDL BioPharma (Nasdaq:PDLI) is tomorrow, December 6, 2011. Owners of shares as of market close today will be eligible for a dividend of 15 cents per share. At a price of $6.36 as of 9:30 a.m., the dividend yield is 9.5%.

PDL BioPharma Inc. Stock Upgraded (PDLI)

PDL BioPharma Inc. Stock Upgraded (PDLI)

PDL BioPharma (Nasdaq:PDLI) has been upgraded by TheStreet Ratings from a sell to hold.

Hedge Fund 13F Stock Picks: Profiting From Idea Season

Hedge Fund 13F Stock Picks: Profiting From Idea Season

Hedge fund manager third quarter stock picks are revealed, and sorting through the 13F filings provides value investing ideas.

TheStreet Quant Rating: C- (Hold)